Gene therapy is not yet possible, but may become feasible soon, particularly for well understood gene defects. Although treatment of a patient raises no ethical problems once it can be done well, changing the genes of an early embryo is more difficult, controversial and unlikely to be required clinically.
Article PDF
References
Orkin, S. H. Nature 296, 202–203 (1982).
Williamson, B. Nature 292, 405–406 (1981).
Prospects for Gene Therapy — Facts and Fiction, (ed. Friedman, T.) (Cold Spring Harbor Laboratory, New York, in the press).
Council of Europe Parliamentary Assembly recommendation 934 (1982).
Ruddle, F. H. Nature 294, 115–120 (1981).
Williamson, B. Nature 293, 10 (1981).
Nature 291, 369 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williamson, B. Gene therapy. Nature 298, 416–418 (1982). https://doi.org/10.1038/298416a0
Published:
Issue Date:
DOI: https://doi.org/10.1038/298416a0
This article is cited by
-
30 years of progress from positional cloning to precision genome editing
Nature Genetics (2022)
-
Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential
Archivum Immunologiae et Therapiae Experimentalis (2010)
-
Germ-line gene therapy and the clinical ethos of medical genetics
Theoretical Medicine (1989)
-
Clustered illegitimate recombination events in mammalian cells involving very short sequence homologies
Nature (1983)